Related Experiment Video
Updated: Aug 22, 2025

Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing
Published on: October 18, 2013
Personalized genome assembly for accurate cancer somatic mutation discovery using tumor-normal paired reference
Chunlin Xiao1, Zhong Chen2, Wanqiu Chen2
1National Center for Biotechnology Information, National Library of Medicine, National Institutes of Health, 45 Center Drive, Bethesda, MD, 20894, USA. xiao2@mail.nih.gov.
Using a personalized genome reference improves cancer mutation detection. This study shows personalized genomes are essential for accurately identifying all somatic mutations in tumor samples, advancing precision oncology.
Area of Science:
- Genomics
- Cancer Research
- Bioinformatics
Background:
- Personalized, haplotype-specific genome assemblies are advocated for cancer mutation detection but lack exploration in tumor-normal paired samples.
- Existing reference genomes like GRCh38 are mosaic and may limit the detection of the full spectrum of somatic events.
Purpose of the Study:
- To demonstrate the first use of a de novo assembled personalized genome as a reference for cancer mutation detection.
- To quantify the impact of reference genomes on the accuracy of somatic mutation detection in paired tumor-normal samples.
Main Methods:
- Generated de novo assemblies of the first tumor-normal paired genomes (nuclear and mitochondrial) from an individual with triple-negative breast cancer.
- Utilized chromosomal-scale, haplotype-phased, and annotated personalized genomes for analysis.
- Compared mutation detection accuracy using personalized versus standard reference genomes.
Main Results:
- Personalized genomes provide individual-specific haplotypes, improving read alignments for both short-read and long-read sequencing data.
- Enhanced accuracy in detecting somatic single nucleotide variants (SNVs) and structural variants (SVs).
- Identified novel somatic mutations exclusively when using the personalized genome assembly as the reference.
Conclusions:
- Personalized genomes with individual-specific haplotypes are crucial for accurate somatic mutation detection in paired tumor-normal samples.
- The developed resource and methodology will advance precision oncology for breast and other cancers.
Related Concept Videos
Cancers Originate from Somatic Mutations in a Single Cell
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

